| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 2.023.577 $ | 94,64 | 90.617 | ||||||
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 171.609 $ | 8,03 | 235 | |
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 166.478 $ | 7,79 | 181 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | 04351P101 | Long | Börsenkurs (Stufe 1) | 117.110 $ | 5,48 | 512 | |
| Nektar Therapeutics | Nektar Therapeutics | EC | 640268306 | Long | Börsenkurs (Stufe 1) | 101.593 $ | 4,75 | 1.412 | |
| Thermo Fisher Scientific Inc | Thermo Fisher Scientific Inc | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 91.425 $ | 4,28 | 186 | |
| Align Technology Inc | Align Technology Inc | EC | 016255101 | Long | Börsenkurs (Stufe 1) | 89.315 $ | 4,18 | 521 | |
| Enliven Therapeutics Inc | Enliven Therapeutics Inc | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 83.339 $ | 3,90 | 2.126 | |
| 10X Genomics Inc | 10X Genomics Inc | EC | 88025U109 | Long | Börsenkurs (Stufe 1) | 80.695 $ | 3,77 | 3.801 | |
| Newamsterdam Pharma Co NV | Newamsterdam Pharma Co NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 76.280 $ | 3,57 | 2.383 | |
| Structure Therapeutics Inc | Structure Therapeutics Inc | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 71.770 $ | 3,36 | 1.489 | |
| Ceribell Inc | Ceribell Inc | EC | 15678C102 | Long | Börsenkurs (Stufe 1) | 71.762 $ | 3,36 | 3.915 | |
| Doximity Inc | Doximity Inc | EC | 26622P107 | Long | Börsenkurs (Stufe 1) | 62.630 $ | 2,93 | 2.688 | |
| Intuitive Surgical Inc | Intuitive Surgical Inc | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 60.851 $ | 2,85 | 132 | |
| Guardant Health Inc | Guardant Health Inc | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 58.285 $ | 2,73 | 631 | |
| Alnylam Pharmaceuticals Inc | Alnylam Pharmaceuticals Inc | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 57.902 $ | 2,71 | 175 | |
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 57.157 $ | 2,67 | 128 | |
| Vaxcyte Inc | Vaxcyte Inc | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 55.321 $ | 2,59 | 952 | |
| Illumina Inc | Illumina Inc | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 53.865 $ | 2,52 | 437 | |
| Inspire Medical Systems Inc | Inspire Medical Systems Inc | EC | 457730109 | Long | Börsenkurs (Stufe 1) | 53.127 $ | 2,48 | 1.030 | |
| Zoetis Inc | Zoetis Inc | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 48.584 $ | 2,27 | 411 | |
| UnitedHealth Group Inc | UnitedHealth Group Inc | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 46.541 $ | 2,18 | 172 | |
| Kymera Therapeutics Inc | Kymera Therapeutics Inc | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 44.477 $ | 2,08 | 534 | |
| Dexcom Inc | Dexcom Inc | EC | 252131107 | Long | Börsenkurs (Stufe 1) | 42.516 $ | 1,99 | 677 | |
| Beam Therapeutics Inc | Beam Therapeutics Inc | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 38.176 $ | 1,79 | 1.602 | |
| West Pharmaceutical Services Inc | West Pharmaceutical Services Inc | EC | 955306105 | Long | Börsenkurs (Stufe 1) | 36.593 $ | 1,71 | 146 | |
| AtaiBeckley Inc | AtaiBeckley Inc | EC | 04650F101 | Long | Börsenkurs (Stufe 1) | 34.894 $ | 1,63 | 9.857 | |
| MaxCyte Inc | MaxCyte Inc | EC | 57777K106 | Long | Börsenkurs (Stufe 1) | 34.746 $ | 1,63 | 49.461 | |
| Veeva Systems Inc | Veeva Systems Inc | EC | 922475108 | Long | Börsenkurs (Stufe 1) | 33.375 $ | 1,56 | 190 | |
| Schrodinger Inc/United States | Schrodinger Inc/United States | EC | 80810D103 | Long | Börsenkurs (Stufe 1) | 28.991 $ | 1,36 | 2.552 | |
| Tempus AI Inc | Tempus AI Inc | EC | 88023B103 | Long | Börsenkurs (Stufe 1) | 26.092 $ | 1,22 | 577 | |
| Ultragenyx Pharmaceutical Inc | Ultragenyx Pharmaceutical Inc | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 15.880 $ | 0,74 | 758 | |
| uniQure NV | uniQure NV | EC | NL0010696654 | Long | Börsenkurs (Stufe 1) | 12.197 $ | 0,57 | 746 | |
| Gesamt | 2.023.577 $ | 94,64 | 90.617 |